DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the ...
SAN FRANCISCO, Feb. 13, 2026 /PRNewswire/ -- Investors in ICON plc (NASDAQ: ICLR) saw the price of their shares drop about 49% during trading on February 12, 2026, after the company disclosed its ...
Hosted on MSN
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Icon PLC (ICLR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important ...
Investigation’s preliminary indications are that 2023 and 2024 revenue may have been overstated by less than 2% for each fiscal year ICON plc, (NASDAQ: ICLR) today announced that it intends to release ...
We recently published 10 Market Beasts Leaving Wall Street in the Dust. ICON PLC (NASDAQ:ICLR) was one of the best performers on Friday. ICON grew its share prices by 16.13 percent on Friday to finish ...
ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results